Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Revenue (2016 - 2025)

Historic Revenue for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $21.2 million.

  • Iradimed's Revenue rose 1569.42% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.5 million, marking a year-over-year increase of 1291.09%. This contributed to the annual value of $73.2 million for FY2024, which is 1171.38% up from last year.
  • Latest data reveals that Iradimed reported Revenue of $21.2 million as of Q3 2025, which was up 1569.42% from $20.4 million recorded in Q2 2025.
  • Iradimed's Revenue's 5-year high stood at $21.2 million during Q3 2025, with a 5-year trough of $9.2 million in Q1 2021.
  • Over the past 5 years, Iradimed's median Revenue value was $16.1 million (recorded in 2023), while the average stood at $15.5 million.
  • The largest annual percentage gain for Iradimed's Revenue in the last 5 years was 4438.36% (2021), contrasted with its biggest fall of 629.73% (2021).
  • Iradimed's Revenue (Quarter) stood at $11.9 million in 2021, then increased by 25.19% to $14.9 million in 2022, then increased by 17.42% to $17.5 million in 2023, then increased by 11.1% to $19.4 million in 2024, then increased by 9.35% to $21.2 million in 2025.
  • Its last three reported values are $21.2 million in Q3 2025, $20.4 million for Q2 2025, and $19.5 million during Q1 2025.